Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Aurinia Pharmaceuticals Inc Is A Biopharmaceutical Company Focused On Delivering Therapies To People Living With Autoimmune Diseases With High Unmet Medical Needs. The Company Developed Lupkynis (Voclosporin), The First Fda-Approved Oral Therapy For The Treatment Of Adult Patients With Active Lupus Nephritis. It Is Also Developing Aritinercept, A Dual Inhibitor Of B Cell Activating Factor (Baff) And A Proliferation-Inducing Ligand (April), For The Potential Treatment Of Autoimmune Diseases.